Role of autophagy in drug resistance and regulation of osteosarcoma (Review)
- Authors:
- Yanchuan Pu
- Jin Wang
- Shizhong Wang
-
Affiliations: Department of Orthopedics, Wuwei People's Hospital, Wuwei, Gansu 733000, P.R. China - Published online on: February 1, 2022 https://doi.org/10.3892/mco.2022.2505
- Article Number: 72
This article is mentioned in:
Abstract
 |
|
Lu KH, Lu EW, Lin CW, Yang JS and Yang SF: New insights into molecular and cellular mechanisms of zoledronate in human osteosarcoma. Pharmacol Ther. 214(107611)2020.PubMed/NCBI View Article : Google Scholar | |
|
Otoukesh B, Abbasi M, Gorgani HO, Farahini H, Moghtadaei M, Boddouhi B, Kaghazian P, Hosseinzadeh S and Alaee A: MicroRNAs signatures, bioinformatics analysis of miRNAs, miRNA mimics and antagonists, and miRNA therapeutics in osteosarcoma. Cancer Cell Int. 20(254)2020.PubMed/NCBI View Article : Google Scholar | |
|
Li Z, Xu D, Chen X, Li S, Chan MTV and Wu WKK: LINC01133: An emerging tumor-associated long non-coding RNA in tumor and osteosarcoma. Environ Sci Pollut Res Int. 27:32467–32473. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Mendes AC, Ciccone M, Gazolla B and Bahia D: Epithelial haven and autophagy breakout in gonococci infection. Front Cell Dev Biol. 8(439)2020.PubMed/NCBI View Article : Google Scholar | |
|
Levine B and Kroemer G: Autophagy in the pathogenesis of disease. Cell. 132:27–42. 2008.PubMed/NCBI View Article : Google Scholar | |
|
Ma W, Wei S, Zhang B and Li W: Molecular mechanisms of cardiomyocyte death in drug-induced cardiotoxicity. Front Cell Dev Biol. 8(434)2020.PubMed/NCBI View Article : Google Scholar | |
|
Lin Y, Zhao WR, Shi WT, Zhang J, Zhang KY, Ding Q, Chen XL, Tang JY and Zhou ZY: Pharmacological activity, pharmacokinetics, and toxicity of timosaponin AIII, a natural product isolated from anemarrhena asphodeloides bunge: A review. Front Pharmacol. 11(764)2020.PubMed/NCBI View Article : Google Scholar | |
|
Liu W, Meng Y, Zong C, Zhang S and Wei L: Autophagy and tumorigenesis. Adv Exp Med Biol. 1207:275–299. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Blondy S, David V, Verdier M, Mathonnet M, Perraud A and Christou N: 5-Fluorouracil resistance mechanisms in colorectal cancer: From classical pathways to promising processes. Cancer Sci. 111:3142–3154. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Condello M, Mancini G and Meschini S: The exploitation of liposomes in the inhibition of autophagy to defeat drug resistance. Front Pharmacol. 11(787)2020.PubMed/NCBI View Article : Google Scholar | |
|
Whelan JS and Davis LE: Osteosarcoma, chondrosarcoma, and chordoma. J Clin Oncol. 36:188–193. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Lim J and Murthy A: Targeting autophagy to treat cancer: Challenges and opportunities. Front Pharmacol. 11(590344)2020.PubMed/NCBI View Article : Google Scholar | |
|
Mele L, Del Vecchio V, Liccardo D, Prisco C, Schwerdtfeger M, Robinson N, Desiderio V, Tirino V, Papaccio G and La Noce M: The role of autophagy in resistance to targeted therapies. Cancer Treat Rev. 88(102043)2020.PubMed/NCBI View Article : Google Scholar | |
|
Yang J, Ueharu H and Mishina Y: Energy metabolism: A newly emerging target of BMP signaling in bone homeostasis. Bone. 138(115467)2020.PubMed/NCBI View Article : Google Scholar | |
|
Tian Y, Song W, Xu D, Chen X, Li X and Zhao Y: Autophagy induced by ROS aggravates testis oxidative damage in diabetes via breaking the feedforward loop linking p62 and Nrf2. Oxid Med Cell Longev. 2020(7156579)2020.PubMed/NCBI View Article : Google Scholar | |
|
Kulka LAM, Fangmann PV, Panfilova D and Olzscha H: Impact of HDAC inhibitors on protein quality control systems: Consequences for precision medicine in malignant disease. Front Cell Dev Biol. 8(425)2020.PubMed/NCBI View Article : Google Scholar | |
|
Ashrafizadeh M, Tavakol S, Ahmadi Z, Roomiani S, Mohammadinejad R and Samarghandian S: Therapeutic effects of kaempferol affecting autophagy and endoplasmic reticulum stress. Phytother Res. 34:911–923. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Liu F, Liu D, Yang Y and Zhao S: Effect of autophagy inhibition on chemotherapy-induced apoptosis in A549 lung cancer cells. Oncol Lett. 5:1261–1265. 2013.PubMed/NCBI View Article : Google Scholar | |
|
Tan Q, Liu Y, Deng X, Chen J, Tsai PJ, Chen PH, Ye M, Guo J and Su Z: Autophagy: A promising process for the treatment of acetaminophen-induced liver injury. Arch Toxicol. 94:2925–2938. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Kim WK, Pyee Y, Chung HJ, Park HJ, Hong JY, Son KH and Lee SK: Antitumor activity of spicatoside A by modulation of autophagy and apoptosis in human colorectal cancer cells. J Nat Prod. 79:1097–1104. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Yecies JL and Manning BD: mTOR links oncogenic signaling to tumor cell metabolism. J Mol Med (Berl). 89:221–228. 2011.PubMed/NCBI View Article : Google Scholar | |
|
Tang D, Loze MT, Zeh HJ and Kang R: The redox protein HMGB1 regulates cell death and survival in cancer treatment. Autophagy. 6:1181–1183. 2010.PubMed/NCBI View Article : Google Scholar | |
|
Niu J, Yan T, Guo W, Wang W and Zhao Z: Insight into the role of autophagy in osteosarcoma and its therapeutic implication. Front Oncol. 9(1232)2019.PubMed/NCBI View Article : Google Scholar | |
|
Zhang J, Kou YB, Zhu JS, Chen WX and Li S: Knockdown of HMGB1 inhibits growth and invasion of gastric cancer cells through the NF-κB pathway in vitro and in vivo. Int J Oncol. 44:1268–1276. 2014.PubMed/NCBI View Article : Google Scholar | |
|
Berindan-Neagoe I, Monroig Pdel C, Pasculli B and Calin GA: MicroRNAome genome: A treasure for cancer diagnosis and therapy. CA Cancer J Clin. 64:311–336. 2014.PubMed/NCBI View Article : Google Scholar | |
|
Gulino R, Forte S, Parenti R, Memeo L and Gulisano M: MicroRNA and pediatric tumors: Future perspectives. Acta Histochem. 117:339–354. 2015.PubMed/NCBI View Article : Google Scholar | |
|
Llobat L and Gourbault O: Role of MicroRNAs in human osteosarcoma: Future perspectives. Biomedicines. 9(463)2021.PubMed/NCBI View Article : Google Scholar | |
|
Mutlu H, Mutlu S and Bostancıklıoğlu M: Profiling of autophagy-associated microRNAs in the osteosarcoma cell line of U2OS. Anticancer Agents Med Chem. 21:1732–1737. 2021.PubMed/NCBI View Article : Google Scholar | |
|
Chen R, Wang G, Zheng Y, Hua Y and Cai Z: Drug resistance-related microRNAs in osteosarcoma: Translating basic evidence into therapeutic strategies. J Cell Mol Med. 23:2280–2292. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Jamali Z, Taheri-Anganeh M, Shabaninejad Z, Keshavarzi A, Taghizadeh H, Razavi ZS, Mottaghi R, Abolhassan M, Movahedpour A and Mirzaei H: Autophagy regulation by microRNAs: Novel insights into osteosarcoma therapy. IUBMB Life. 72:1306–1321. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Xia H and Hui KM: Mechanism of cancer drug resistance and the involvement of noncoding RNAs. Curr Med Chem. 21:3029–3041. 2014.PubMed/NCBI View Article : Google Scholar | |
|
Wang G, Shen N, Cheng L, Lin J and Li K: Downregulation of miR-22 acts as an unfavorable prognostic biomarker in osteosarcoma. Tumour Biol. 36:7891–7895. 2015.PubMed/NCBI View Article : Google Scholar | |
|
Li X, Wang S, Chen Y, Liu G and Yang X: miR-22 targets the 3' UTR of HMGB1 and inhibits the HMGB1-associated autophagy in osteosarcoma cells during chemotherapy. Tumour Biol. 35:6021–6028. 2014.PubMed/NCBI View Article : Google Scholar | |
|
Xu S, Gong Y, Yin Y, Xing H and Zhang N: The multiple function of long noncoding RNAs in osteosarcoma progression, drug resistance and prognosis. Biomed Pharmacother. 127(110141)2020.PubMed/NCBI View Article : Google Scholar | |
|
Pitolli C, Wang Y, Candi E, Shi Y, Melino G and Amelio I: p53-Mediated tumor suppression: DNA-damage response and alternative mechanisms. Cancers (Basel). 11(1983)2019.PubMed/NCBI View Article : Google Scholar | |
|
Zhang W, Li Q, Song C and Lao L: Knockdown of autophagy-related protein 6, Beclin-1, decreases cell growth, invasion, and metastasis and has a positive effect on chemotherapy-induced cytotoxicity in osteosarcoma cells. Tumour Biol. 36:2531–2539. 2015.PubMed/NCBI View Article : Google Scholar | |
|
Xu R, Liu S, Chen H and Lao L: MicroRNA-30a downregulation contributes to chemoresistance of osteosarcoma cells through activating Beclin-1-mediated autophagy. Oncol Rep. 35:1757–1763. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Heras-Sandoval D, Pérez-Rojas JM, Hernández-Damián J and Pedraza-Chaverri J: The role of PI3K/AKT/mTOR pathway in the modulation of autophagy and the clearance of protein aggregates in neurodegeneration. Cell Signal. 26:2694–2701. 2014.PubMed/NCBI View Article : Google Scholar | |
|
Li M, Hou Y, Wang J, Chen X, Shao ZM and Yin XM: Kinetics comparisons of mammalian Atg4 homologues indicate selective preferences toward diverse Atg8 substrates. J Biol Chem. 286:7327–7338. 2011.PubMed/NCBI View Article : Google Scholar | |
|
Shi M, Zhang T, Sun L, Luo Y, Liu DH, Xie ST, Song XY, Wang GF, Chen XL, Zhou BC and Zhang YZ: Calpain, Atg5 and Bak play important roles in the crosstalk between apoptosis and autophagy induced by influx of extracellular calcium. Apoptosis. 18:435–451. 2013.PubMed/NCBI View Article : Google Scholar | |
|
Guo Y, Huang C, Li G, Chen T, Li J and Huang Z: Paxilitaxel induces apoptosis accompanied by protective autophagy in osteosarcoma cells through hypoxia-inducible factor-1α pathway. Mol Med Rep. 12:3681–3687. 2015.PubMed/NCBI View Article : Google Scholar | |
|
Peng B, Xu L, Cao F, Wei T, Yang C, Uzan G and Zhang D: HSP90 inhibitor, celastrol, arrests human monocytic leukemia cell U937 at G0/G1 in thiol-containing agents reversible way. Mol Cancer. 9(79)2010.PubMed/NCBI View Article : Google Scholar | |
|
Kannaiyan R, Manu KA, Chen L, Li F, Rajendran P, Subramaniam A, Lam P, Kumar AP and Sethi G: Celastrol inhibits tumor cell proliferation and promotes apoptosis through the activation of c-Jun N-terminal kinase and suppression of PI3 K/Akt signaling pathways. Apoptosis. 16:1028–1041. 2011.PubMed/NCBI View Article : Google Scholar | |
|
Sethi G, Ahn KS, Pandey MK and Aggarwal BB: Celastrol, a novel triterpene, potentiates TNF-induced apoptosis and suppresses invasion of tumor cells by inhibiting NF-kappaB-regulated gene products and TAK1-mediated NF-kappaB activation. Blood. 109:2727–2735. 2007.PubMed/NCBI View Article : Google Scholar | |
|
Yang H, Chen D, Cui QC, Yuan X and Dou QP: Celastrol, a triterpene extracted from the Chinese ‘Thunder of God Vine,’ is a potent proteasome inhibitor and suppresses human prostate cancer growth in nude mice. Cancer Res. 66:4758–4765. 2006.PubMed/NCBI View Article : Google Scholar | |
|
Hou W, Liu B and Xu H: Celastrol: Progresses in structure-modifications, structure-activity relationships, pharmacology and toxicology. Eur J Med Chem. 189(112081)2020.PubMed/NCBI View Article : Google Scholar | |
|
Beauchamp EM and Uren A: A new era for an ancient drug: Arsenic trioxide and Hedgehog signaling. Vitam Horm. 88:333–354. 2012.PubMed/NCBI View Article : Google Scholar | |
|
Hashmi H and Nishihori T: Role of hematopoietic cell transplantation in relapsed acute promyelocytic leukemia. Clin Transplant. 34(e14009)2020.PubMed/NCBI View Article : Google Scholar | |
|
Zhang G, Liu J, Zhang Y, Qu J, Xu L, Zheng H, Liu Y and Qu X: Cbl-b-dependent degradation of FLIP(L) is involved in ATO-induced autophagy in leukemic K562 and gastric cancer cells. FEBS Lett. 586:3104–3110. 2012.PubMed/NCBI View Article : Google Scholar | |
|
Jóźwiak S, Sadowski K, Kotulska K and Schwartz RA: Topical use of mammalian target of rapamycin (mTOR) inhibitors in tuberous sclerosis complex-A comprehensive review of the literature. Pediatr Neurol. 61:21–27. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Garza-Lombó C and Gonsebatt ME: Mammalian target of rapamycin: Its role in early neural development and in adult and aged brain function. Front Cell Neurosci. 10(157)2016.PubMed/NCBI View Article : Google Scholar | |
|
Pulakat L and Chen HH: Pro-senescence and anti-senescence mechanisms of cardiovascular aging: Cardiac MicroRNA regulation of longevity drug-induced autophagy. Front Pharmacol. 11(774)2020.PubMed/NCBI View Article : Google Scholar | |
|
Wang J, Li X, Zhong M, Wang Y, Zou L, Wang M, Gong X, Wang X, Zhou C, Ma X and Liu M: miR-301a suppression within fibroblasts limits the progression of fibrosis through the TSC1/mTOR pathway. Mol Ther Nucleic Acids. 21:217–228. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Cao L and Niu Y: Triple negative breast cancer: special histological types and emerging therapeutic methods. Cancer Biol Med. 17:293–306. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Saraf AJ, Fenger JM and Roberts RD: Osteosarcoma: Accelerating progress makes for a hopeful future. Front Oncol. 8(4)2018.PubMed/NCBI View Article : Google Scholar | |
|
Kocaturk NM, Akkoc Y, Kig C, Bayraktar O, Gozuacik D and Kutlu O: Autophagy as a molecular target for cancer treatment. Eur J Pharm Sci. 134:116–137. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Ebrahimi S, Hosseini M, Shahidsales S, Maftouh M, Ferns GA, Ghayour-Mobarhan M, Hassanian SM and Avan A: Targeting the Akt/PI3K signaling pathway as a potential therapeutic strategy for the treatment of pancreatic cancer. Curr Med Chem. 24:1321–1331. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Bernardo PS, Lemos LGT, de Moraes GN and Maia RC: Unraveling survivin expression in chronic myeloid leukemia: Molecular interactions and clinical implications. Blood Rev. 43(100671)2020.PubMed/NCBI View Article : Google Scholar | |
|
Waligórska-Stachura J, Jankowska A, Waśko R, Liebert W, Biczysko M, Czarnywojtek A, Baszko-Błaszyk D, Shimek V and Ruchała M: Survivin-prognostic tumor biomarker in human neoplasms-review. Ginekol Pol. 83:537–540. 2012.PubMed/NCBI | |
|
Khan Z, Khan AA, Yadav H, Prasad GBKS and Bisen PS: Survivin, a molecular target for therapeutic interventions in squamous cell carcinoma. Cell Mol Biol Lett. 22(8)2017.PubMed/NCBI View Article : Google Scholar | |
|
Coumar MS, Tsai FY, Kanwar JR, Sarvagalla S and Cheung CH: Treat cancers by targeting survivin: Just a dream or future reality? Cancer Treat Rev. 39:802–811. 2013.PubMed/NCBI View Article : Google Scholar | |
|
Church DN and Talbot DC: Survivin in solid tumors: Rationale for development of inhibitors. Curr Oncol Rep. 14:120–128. 2012.PubMed/NCBI View Article : Google Scholar | |
|
Agostinis P, Berg K, Cengel KA, Foster TH, Girotti AW, Gollnick SO, Hahn SM, Hamblin MR, Juzeniene A, Kessel D, et al: Photodynamic therapy of cancer: An update. CA Cancer J Clin. 61:250–281. 2011.PubMed/NCBI View Article : Google Scholar | |
|
Calabrò G, Patalano A, Lo Conte V and Chianese C: Photodynamic chemotherapy in the treatment of superficial mycoses: An evidence-based evaluation. G Ital Dermatol Venereol. 148:639–648. 2013.PubMed/NCBI | |
|
Carina V, Costa V, Sartori M, Bellavia D, De Luca A, Raimondi L, Fini M and Giavaresi G: Adjuvant biophysical therapies in osteosarcoma. Cancers (Basel). 11(348)2019.PubMed/NCBI View Article : Google Scholar |
